scispace - formally typeset
T

Tom Venken

Researcher at Katholieke Universiteit Leuven

Publications -  25
Citations -  267

Tom Venken is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 9, co-authored 16 publications receiving 201 citations. Previous affiliations of Tom Venken include University of Bergen & Flemish Institute for Technological Research.

Papers
More filters
Journal ArticleDOI

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer.

TL;DR: Methylation changes underlying EMT are proposed to constitute a common resistance mechanism to cancer therapies and can be reversed pharmacologically and monitored non-invasively in ctDNA to predict resistance to treatment.
Journal ArticleDOI

An optimized MM/PBSA virtual screening approach applied to an HIV-1 gp41 fusion peptide inhibitor.

TL;DR: In this paper, molecular dynamics were executed in combination with molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) free energy calculations to explore the binding interaction between VIRIP derivatives and gp41 FP.
Journal ArticleDOI

A novel method for hydrophobin extraction using CO2 foam fractionation system

TL;DR: The gushing potential of samples revealed that in contrast to the samples before CO 2 treatment, interestingly, no gushing was observed for the samples after treatment and the possibility that stable aggregates of HFBII molecules are formed as a consequence of their high concentration is discussed in this paper.
Journal ArticleDOI

pKa Modulation of the Acid/Base Catalyst within GH32 and GH68: A Role in Substrate/Inhibitor Specificity?

TL;DR: It is strongly suggested that a highly conserved arginine residue (in the RDP motif) rather than the previously proposed Tyr motif provides the proton to increase the pKa of the acid-base catalyst.